Apply now: Bristol Myers Squibb’s Golden Ticket—$50K lab credit to LabCentral >

Press Releases

HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders

May 17, 2018

Share :